Malignant pleural mesothelioma (MPM) is a rare asbestosrelated tumor. The prognosis is dismal: the median overall survival times range between 11 and 12 months with 4-6 cycles of cis /carboplatin and antifolate chemotherapy, which is currently considered the standard of care [1] [2] [3] [4] . Nevertheless, the best treatment option remains controversial [1, [4] [5] [6] . The survival benefit of very aggressive surgical techniques, such as extrapleural pneumonectomy (EPP), is unclear [5] . Furthermore, the interest towards the use of novel systemic agents (i.e. targeted agents or immunotherapy) together with cis-/carboplatin and antifolate chemotherapy in MPM is growing [7] . In particular, the combination of radiotherapy (RT) with immune treatment is appealing, also for MPM [8, 9] . In order to investigate appropriately delivered RT in combination with novel agents in the nonsurgical setting, RT should be delivered safely to the hemi-thoracic pleura without undue lung damage. Lung-sparing intensity modulated radiation therapy (IMRT) (alone or after P/D) has been proven feasible and safe [10] [11] [12] [13] [14] [15] [16] . However, lung-sparing IMRT needs to be further optimized. The optimal gross tumor volume (GTV) definition has not been defined yet. According to the recommendations of the Asbestos Diseases Research Institute, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) is considered the standard technique for the N-and M-staging in MPM (level of the recommendation A) [17] . However, there is increasing evidence that magnetic resonance imaging (MRI) can be helpful in the pre-operative staging (especially the T-staging) [18, 19] . It is therefore likely that, similar to the staging (in particular the T-staging), the integration of MRI in GTV definition will improve the accuracy for tumor delineation (especially the pleural component), hence reducing the probability of geographical miss and increasing the probability of tumor control. The aim of the present study is to investigate the effect of incorporating MRI findings into the GTV definition in MPM patients treated with hemi-thoracic lung-sparing IMRT. As the standard Nstagingconsists of a combination of PET/CT and, in some cases, from invasive procedures (e.g. mediastinoscopy), and not MRI, the GTV definition of the lymph nodes was excluded, and is beyond the scope of this article.
Material and methods

Patients
Patients newly diagnosed with biopsy-proven and previously untreated stage I-IV MPM between January 2010 and December 2013 at our institution were retrospectively identified from a prospective institutional database. Eligibility criteria were: to have a staging CT scan with intravenous contrast (IVC), MRI and 18F-FDG-PET/CT, all performed in our institution. Patients with prior pleurodesis wereexcluded. The institutional database consisted of 66 patients: 16 of them met the eligibility criteria and were included in the study. The overwhelming majority of noneligible patients did not undergo staging MRI or PET/CT at our institution (42 patients), whereas eight patients were excluded because they underwent pleurodesis before staging MRI or PET/CT staging. Patients were staged using the staging system of the International Mesothelioma Interest Group [20] .
Thoracic imaging and imaging processing
CT scans with IVC and PET/CT were acquired in free breathing. Patients were scanned in supine position, with both arms raised above their head. MRI was acquired in breath hold and patients were scanned in supine position, with both arms down positioned. PET/CT scans were acquired with an integrated PET/CT scanner (Biograph TruePoint V; Siemens Healthcare, Erlangen, Germany) including a 40-section CT scanner. Patients received an intravenous injection of 18F-FDG, and rested for 60 minutes before imaging [activity (Bq)¼(body weight_4)þ20]. Each examination consisted of a whole body spiral CT scan with IVC followed by a whole body PET acquisition, obtained in the identical transverse plane, and coregistration between the two sets of images was provided. The PET imaging data were reconstructed using an ordered subset expectation maximization algorithm and attenuation corrections derived from CT data. Slice thickness was 3 mm. MRI scans were performed with a 3-Tesla whole body system (Achieva; Philips Healthcare, Best, The Netherlands) with the manufacturer's 16-channel phased array torso coil (Sense XL Torso; Philips Healthcare) for signal reception. Nonenhanced T2-weighted turbo spin-echo sequence, a T1-weighted fat-suppressed sequence and a contrast-enhanced T1 sequence were performed in the transverse and coronal plane. Slice thickness was 3 mm. CT with IVC, PET/CT and MRI scans were retrieved from the hospital images archiving and communication system, exported and saved in an image fusion workstation (MIM Software Inc., Cleveland, OH, USA) for image registration and contouring. Two different sets of rigid co-registrations were created: the first one between CT with IVC and PET/CT and the second one between CT with IVC and MRI. The rigid registration has been performed automatically with the MIM algorithm (an intensity-based algorithm) (MIM Software Inc.). The region of interest encompassed the ipsilateral thorax.
GTV definition and contours' analysis
Only the GTV of the primary tumor was taken into account and contoured. As the standard Nstaging consists of a combination of the functional PET/CT information and, in some cases, from invasive procedures such as mediastinoscopy, and not MRI, the GTV definition of the lymph nodes was excluded, and is beyond the scope of this article. For each patient, three different GTVs were contoured separately by a radiation oncologist experienced in thoracic oncology, and independently checked by a second radiation oncologist. In case of variation, a consensus was agreed upon:
1. A CT-based GTV (GTVCT), manually outlined on the CT with IVC scan; 2. A PET/CT-based GTV (GTVCTþPET/CT), manually outlined on the CT with IVC scan rigidly co registered to the PET/CT scan;
3. An MRI-based GTV (GTVCTþMRI), manually outlined on the CT with IVC scan rigidly coregistered to the MRI images (T1, T2 and contrast-enhanced T1-sequences).
The first volume to be contoured was always the GTVCT, followed by the contouring of the GTVCTþPET/CT and GTVCTþMRI. The GTVCT was contoured without knowing the PET/CT scan and the MRI scan data, thus resulting into a blinded interpretation of the raw CT data. Included into the GTVCT was any pleural thickening (nodular, mediastinal, parietal, circumferential) on the CT scan [21, 22] .
The GTVCTþPET/CT and GTVCTþMRI were respectively a hybrid CTþPET/CT volume and a hybrid CTþMRI volume. These hybrid volumes were not strictly the union between the CT and the PET or the CT and the MRI target volumes: the initially performed GTVCT was modified on the basis of the findings on PET/CT scans and MRI scans. Included into the GTVCTþPET/CT was any pleural thickening, with any abnormal FDG uptake defined visually. A non-FDG-avid pleural thickening was included into the GTVCTþPET/CT, given the low diagnostic sensitivity of the FDG-PET in defining MPM disease [21] . No SUV threshold was used, as to our knowledge there is no consensus about the most appropriate SUV threshold to discriminate benign from malignant lesions in MPM [23, 24] . Included into the GTVCTþMRI was any moderately hyperintense pleural thickening (relatively to muscle on T1 or T2 images) or enhancing after administration of gadoliniumbased contrast material.
Statistics
GTVCT, GTVCTþPET/CT and GTVCTþMRI were compared quantitatively and qualitatively. A quantitative comparison was carried out by investigating the following parameters:
1. Mean, median, standard deviation (SD) and range of the different GTVs per imaging modality. 2. Coefficient of variation (COV), a normalized measure of the dispersion of a distribution. This is defined as the ratio of the SD to the mean: COV¼SD/mean. Three COVs were obtained: COV GTVCT, COV GTVCTþPET/CT and COV GTVCTþMRI. 3. Jaccard Index (JI), a measure of the overlap between two GTVs. All possible combinations for JI calculations were exploited, and three pairwise comparisons were thus identified, as follows: GTVCT versus GTVCTþPET/CT, GTVCT versus GTVCTþMRI, GTVCTþPET/CT versus GTVCTþMRI.
Those quantitative parameters were identified according to the paper published by Fotina et al. on the more adequate metrics to report inter-observer variability in target delineation in RT contouring studies [25] . A qualitative comparison was performed through visual assessment. For each patient, three comparisons were made: 1. PET/CT versus CT with IVC; 2. MRI versus CT with IVC; 3. MRI versus PET/CT.
For each comparison, the radiation oncologists identified the patients in whom PET/CT (a) and the MRI (b and c) showed at least one additional tumor site (or additional tumor location within a site) compared to the CT with IVC (aand b) and the PET/CT (c), respectively. Eight sites were identified: diaphragm, parietal pleura, mediastinal pleura, pericardial pleura, fissural pleura, chest wall, mediastinal fat and costo-phrenic sinus. The additional tumor site or the additional tumor location within a site were defined either as new site separate (not identified before) or as new locations within a site (i.e. new nodules or greater extent of known tumors).Statistical analysis was performed using the software package Statistica 11TM (StatSoft Inc., Tulsa, OK). A two-tailed paired t-test was performed to compare continuous variables (once the normality of the distribution of the means was confirmed). A v2-test was used for categorical variables. Bonferroni correction for multiple testing was applied; a p-value <0.016 (alpha error/3) was considered statistically significant.
Ethics
This was a retrospective contouring study, and patients were diagnosed and treated previously according to standard institutional guidelines. No informed consent was needed according to the policy of the local clinical trial center.
Results
Relevant patients and tumor characteristics are summarized in Table 1 . Sixteen patients were included, 12 men and four women, nine right-sided and seven left-sided. Their median age was 62 years (range: 64-69 years).
Additional tumor sites (qualitative evaluation)
A detailed description is provided in Tables 2 and 3 and an example is showed in Figure 1 . PET/CT identified additional tumor sites in 12/16 patients, compared to CT-based GTV definition. This new tumor site was the diaphragm in 7/12 cases. MRI identified additional tumor sites in 15/16 patients compared to either CT scan or PET/CT-based GTV definition. MRI managed to identify more additional tumor sites on CT scans compared to those identified through PET/CT, in particular in the diaphragm (13/15 patients; p¼.001), the parietal pleura (11/15 patients; p¼.001) and the chest wall (5/15 patients; p¼.07) ( Table 2 ). When MRI was compared to PET/CT, new tumor sites were: parietal pleura (9/15 patients), diaphragm (7/15 patients) and chest wall (5/15 patients). The number of additional tumor sites identified by MRI on PET/CT compared to those identified by MRI on CT was not statistically significant ( Table 2) .
Quantitative evaluation
1. An overview of the different GTVs according to the imaging modality is provided in Table 4 . The mean GTVCT, GTVCTþPET/CT and GTVMRI were 630.1 cm3 (SD: 302.81), 640.23 cm3 (SD: 302.83) and 660.8 cm3 (SD: 290.8), respectively. The differences between the mean volumes were not statistically significant (Table 4) .
2. COV values of 0.44 were lower in the GTVCTþMRI (compared to 0.49 for GTVCT and 0.48 for GTVCTþPET/CT), indicating a slightly lower dispersion of the values in the MRI-based volumes (Table 4) .
3. When examining the concordance between volumes with the three pairwise comparisons, the mean JI ± SD was 0.97 ± 0.02 for GTVCT versus GTVCTþPET/CT, 0.91 ± 0.06 for GTVCT versus GTVCTþMRI and 0.91 ± 0.05 for GTVCTþCT/PET versus GTVCTþMRI. Supplementary Table 1 (available online at http://www.informahealthcare.com) shows the results of the t-test, indicating a lower (and statistically very significant) concordance between MRIbased volume versus non-MRIbased volumes (p¼.0007 and p¼.0001).
Discussion
MPM is still a devastating disease with only a very limited proportion of patients experiencing longterm survival. As the prognosis remains poor even after a very extensive surgery such as EPP and given the lack of survival benefit of P/D,there is growing interest in combining RT with novel interventions such as immune therapy [8, 9] . In the latter case, a therapeutic RT dose to the tumor, together with immune interventions, may lead to a systemic cancer effect. RT should be delivered to an adequately high dose, without harming the underlying lung and the others organs at risk. Although GTV definition is crucial for optimal IMRT, to the best of our knowledge, this has never been specifically investigated in lung-sparing IMRT for MPM so far. In all published experiences of lung-sparing IMRT in MPM, irradiation of the whole pleura has been performed [10] [11] [12] [13] [14] [15] [16] . The clinical target volume (CTV) consisted of the whole pleural space, contoured from the lung apex to the diaphragm insertion (T12-L2). Median doses to the planning target volume ranged from 47 to 50 Gy [10] [11] [12] [13] [14] [15] [16] . In all cases, PET/CT was frequently (but not routinely) used to modify the CTV, with the inclusion of any FDG-avid area. None of the abovementioned studies included MRI in the GTV/CTV definition. However, in diagnostic radiology, MRI is considered the gold standard for the T-staging process (in particular the T-staging for the chest wall and the diaphragm) [1, 18, 19] . It is therefore likely that, as for the staging (in particular the T-staging), the integration of MRI in GTV definition will improve the accuracy for tumor delineation (especially the pleural component).
In our study, MRI allowed to avoid potential sites of geographical miss in 15/16 CT-based and PET/CT-based GTVs. Those differences in MRI-based GTV delineation were confined to the diaphragm (dome and insertion), the parietal pleura and the chest wall. Although a JI ranging from 0.91 to 0.97 indicates a very high overlap between volumes, the lowest concordance was registered when MRI-based volumes were compared to CT-and PET/CT-based volumes (with a high statistical significance). Differences between volumes were mild and not statistically significant. Including the MRI in the pleural GTV definition for lungsparing IMRT for pleural mesothelioma may allow a geographic miss to be avoided (especially in the diaphragm, in the parietal pleura and the chest wall), even if the differencein terms of volumes is small and not significant. In the aforementioned cases, those parts of the tumor that would not be included in the GTV would only receive a very low radiation dose, which might decrease the chance for obtaining tumor control substantially. Caveats of our study include: the relatively small sample size, the retrospective nature of the study, the absence of gated images and the rigid co-registration between different imaging modalities (sub-optimal fusion). Concerning the registration method, we used a rigid registration method. The use of deformable image registration (DIR) in multimodal registration is far from being without uncertainties [26] . Moreover, MPM is a very challenging tumor scenario, with differences in breathing status between the imaging modalities and the large tumor volumes. This dramatically increases the uncertainties in image registration [26] . To our knowledge, only one group reported on experimental state-of-theart DIR solutions for multimodal CT-MRI registration in thethoracic region [27] . They concluded that the quantitative results showed 'a large variation of the target registration for all methods', showing differences in registration of up to 3 cm in the cranio-caudal direction [27] . Therefore, we used a rigid registration for the CT-MRI co-registration, and visually assessed the accuracy of the contours slice by slice. Moreover, an intrinsic deficiency of the study is the assumption that additional potential tumor sites discovered with imaging actually represent additional areas of disease. Ideally, the gold standard should be represented by a pathologic confirmation, with a complete mapping of the parietal and visceral pleura, and a comparison with CT with IVC, FDG-PET and MRI, but such a study will be very complex (if not impossible) to realize. However, the studies that correlated pathologic and radiologic findings [18, 19] were mostly designed to distinguish between resectable (i.e. T3) and unresectable (i.e.T4) tumors, whereas for target volume definition the exact boundaries of the tumor should be known. Keeping these shortcomings in mind, the integration of T1/T2-weighted MRI into the gross tumor definition would have potentially avoided geographical miss in 15/16 patients. Therefore, this study supports the integration of thoracic MRIin pleural GTV definition for lung-sparing IMRT for pleural mesothelioma.
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